- Home
- MVT vs OSUR Comparison
MVT vs OSUR Comparison
Compare MVT & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVT
- OSUR
- Stock Information
- Founded
- MVT 1993
- OSUR 2000
- Country
- MVT United States
- OSUR United States
- Employees
- MVT N/A
- OSUR N/A
- Industry
- MVT Investment Bankers/Brokers/Service
- OSUR Medical/Dental Instruments
- Sector
- MVT Finance
- OSUR Health Care
- Exchange
- MVT Nasdaq
- OSUR Nasdaq
- Market Cap
- MVT 213.4M
- OSUR 233.4M
- IPO Year
- MVT N/A
- OSUR 1986
- Fundamental
- Price
- MVT $10.13
- OSUR $2.76
- Analyst Decision
- MVT
- OSUR Hold
- Analyst Count
- MVT 0
- OSUR 1
- Target Price
- MVT N/A
- OSUR $3.00
- AVG Volume (30 Days)
- MVT 49.7K
- OSUR 519.4K
- Earning Date
- MVT 01-01-0001
- OSUR 08-05-2025
- Dividend Yield
- MVT 4.15%
- OSUR N/A
- EPS Growth
- MVT N/A
- OSUR N/A
- EPS
- MVT N/A
- OSUR N/A
- Revenue
- MVT N/A
- OSUR $138,533,000.00
- Revenue This Year
- MVT N/A
- OSUR N/A
- Revenue Next Year
- MVT N/A
- OSUR $6.80
- P/E Ratio
- MVT N/A
- OSUR N/A
- Revenue Growth
- MVT N/A
- OSUR N/A
- 52 Week Low
- MVT $8.96
- OSUR $2.36
- 52 Week High
- MVT $11.17
- OSUR $4.61
- Technical
- Relative Strength Index (RSI)
- MVT 49.55
- OSUR 36.43
- Support Level
- MVT $10.13
- OSUR $2.74
- Resistance Level
- MVT $10.32
- OSUR $2.96
- Average True Range (ATR)
- MVT 0.09
- OSUR 0.15
- MACD
- MVT 0.01
- OSUR -0.04
- Stochastic Oscillator
- MVT 52.50
- OSUR 12.99
About MVT Blackrock MuniVest Fund II Inc.
Blackrock Munivest Fund II Inc is a closed-end management investment company. The fund's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Health, Utilities, Education, Housing, and other sectors.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.